Extracorporeal Cardiac Shock Wave Therapy (CSWT) for Treatment of Coronary Artery Disease in China

Guo Tao; Wang Yu; Peng Yunzhu; kmsyyyp; hyflykm

Authors

Guo Tao
Wang Yu
Peng Yunzhu
kmsyyyp
hyflykm

Keywords:

extracorporeal cardiac shock wave therapy, myocardial infarction, ventricular remodeling, angio genesis

Abstract

Coronary artery disease (CAD) is a leading cause of mortality worldwide. Common therapies in the treatment of CAD are invasive, insufficient and pose additional risks in patients with advanced refractory CAD. Cardiac shock wave therapy (CSWT) is a safe and effective non-invasive intervention in the management of patients with refractory CAD. In this article, we briefly outline our work in animals and humans, and discuss the advantages and perspectives of CSWT in China.

Downloads

How to Cite

Extracorporeal Cardiac Shock Wave Therapy (CSWT) for Treatment of Coronary Artery Disease in China. (2014). Global Journal of Medical Research, 14(37), 9-15. https://medicalresearchjournal.org/index.php/GJMR/article/view/

Download Citation

References

Shimokawa Nishida T, Tatewaki Oi K, Kohtaru Uwatoku T, Kajihara Matsumoto Y, Matsuda Eto M, Takeshita Yasui H (2004) Extracorporeal Cardiac Shock Wave Therapy Markedly Ameliorates Ischemia-Induced Myocardial Dysfunction in Pigs in Vivo. 110, 3055-3061.

Uwatoku T, Ito K, Kohtaro A, Oi K, Hizume T, Sunagawa K, Shimokawa H (2007) Extracorporeal cardiac shock wave therapy improves left ventricular remodeling after acute myocardial infarction in pigs. 18, 397-404.

Ito Fukumoto Y, Matoba Uwatoku T, Tanaka Kishi T, Sunagawa Takeshita A (2006) Extracorporeal cardiac shock wave therapy ameliorates myocardial ischemia in patients with severe coronary artery disease. 17, 63-70.

Ito Shimokawa H, Fukumoto Y (2008) Extracorporeal cardiac shock wave therapy for ischemic heart disease. 17, 449-455.

J. Int (2007) Khattab AA, Brodersen B, Schuermann-Kuchenbrandt D, Beurich H, Tölg R, Geist V, Schäfer T, Richardt G.: Extracorporeal cardiac shock wave therapy: first experience in the everyday practice for treatment of chronic refractory angina pectoris. 121, 84-85.

Christian Prinz, Oliver Lindner, Thomas Bitter, Detlef Hering, Wolfgang Burchert, Dieter Horstkotte, Lothar Faber (2009) Prinz C, Lindner O, Bitter T, Hering D, Burchert W, Horstkotte D, Faber L: Extracorporeal cardiac shock wave therapy ameliorates clinical symptoms and improves regional myocardial blood flow in a patient with severe coronary artery disease and refractory angina. 2009, 1-3. https://doi.org/10.1155/2009/639594

Gutersohn A, Gaspari G. (2000) Shock waves upregulate vascular endothelial growth factor m-RNA in human umbilical vascular endothelial cells. 102(supll), 1-18.

J. Tohoku (2009) Ito K, Fukumoto Y, Shimokawa H: Extracorporeal shock wave therapy as a new and non-invasive angiogenic strategy. 219, 19.

J. Circ (2010) Kikuchi Y, Ito K, Ito Y, et al.: Double-blind and placebo-controlled study of the effectiveness and safety of extracorporeal cardiac shock wave therapy for severe angina pectoris. 74(3), 589-591. https://doi.org/10.1253/circj.cj-09-1028

Hadzegova Vasyuk YA, Shkolnik EL (2010) Initial clinical experience with extracorporeal shock wave therapy in treatment of ischemic heart failure. 16, 226-230.

J. Int (2007) Khattab AA, Brodersen B, Schuermann-Kuchenbrandt D, et al.: Extracorporeal cardiac shock wave therapy: first experience in the everyday practice for treatment of chronic refractory angina pectoris. 121(1), 84-85. https://doi.org/10.1016/j.ijcard.2006.08.030

Cai HY, Wang Y, Li L (2010) Changes in the number of endothelial progenitor cells from peripheral blood in patients with coronary atherosclerotic heart disease before and after extracorporeal cardiac shock wave therapy. 14(49), 9249-9252.

Cai HY, Wang Y, Li L (2010) Effect of extracorporeal cardiac shock wave therapy on vascular endothelial growth factor and circulating endothelial progenitor cells in patients with coronary atherosclerotic heart disease. 14(36), 6755-6758.

S. Tao, T. Guo, Y. Wang (2010) Effects of low-energy extracorporeal shock wave on myocardial matrix metalloproteinase system and ischemic myocardial capillary density after acute myocardial infarction. 14(37), 6979-6984.

S. Tao, T. Guo, Y. Wang (2012) Effect of extracorporeal cardiac shock wave therapy on left ventricular remodeling in a porcine model of acute myocardial infarction. 16(24), 4453-4458.

Shuai Sun, Tao Guo (2010) e0221 Effects of extracorporeal cardiac shock wave therapy on expression of endothelial nitric oxide synthase and basic fibroblast growth factor in swine with acute myocardial infarction. 96(Suppl 3), A71.2-A71. https://doi.org/10.1136/hrt.2010.208967.221

S. Sun, T. Guo (2010) Influence of CSWT on Express of Serum Endothelial Nitric Oxide Synthase in Minipigs with Acute Myocardial Infarction. 13(15), 1660-1663.

Sun S, Guo T (2010) Expression of serum endothelial nitric oxide synthase in pigs following acute myocardial infarction：Influencing ways of extracorporeal cardiac shock wave therapy. 14(9), 1649-1652.

Guo Wang Y, Cai HY (2010) Cardiac Shock Wave Therapy Reduces Angina and Improves Myocardial Function in Patients With Refractory Coronary Artery Disease. 33, 693-699.

(2010) Wang Y, Guo T, Cai H, et al.: [Extracorporeal cardiac shock wave therapy for treatment of coronary artery disease.] Chin J Cardiol 2010. 38, 711-715.

(2012) Randomized and double-blind controlled clinical trial of extracorporeal cardiac shock wave therapy for coronary heart disease. 0380-012. https://doi.org/10.1007/s00380-012-0244-7

Y. Peng, T. Guo, P. Yang (2012) Effects of extracorporeal cardiac shock wave therapy in patients with ischemic heart failure. 40(2), 141-146.